- Home
- ALTG vs MGNX Comparison
ALTG vs MGNX Comparison
Compare ALTG & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- MGNX
- Stock Information
- Founded
- ALTG 1984
- MGNX 2000
- Country
- ALTG United States
- MGNX United States
- Employees
- ALTG N/A
- MGNX N/A
- Industry
- ALTG Industrial Machinery/Components
- MGNX Biotechnology: Pharmaceutical Preparations
- Sector
- ALTG Industrials
- MGNX Health Care
- Exchange
- ALTG Nasdaq
- MGNX Nasdaq
- Market Cap
- ALTG 239.8M
- MGNX 202.7M
- IPO Year
- ALTG N/A
- MGNX 2013
- Fundamental
- Price
- ALTG $6.45
- MGNX $2.76
- Analyst Decision
- ALTG Buy
- MGNX Hold
- Analyst Count
- ALTG 4
- MGNX 10
- Target Price
- ALTG $15.75
- MGNX $7.17
- AVG Volume (30 Days)
- ALTG 114.1K
- MGNX 768.5K
- Earning Date
- ALTG 03-05-2025
- MGNX 03-06-2025
- Dividend Yield
- ALTG 3.54%
- MGNX N/A
- EPS Growth
- ALTG N/A
- MGNX N/A
- EPS
- ALTG N/A
- MGNX N/A
- Revenue
- ALTG $1,900,000,000.00
- MGNX $141,329,000.00
- Revenue This Year
- ALTG $1.40
- MGNX $174.73
- Revenue Next Year
- ALTG $2.42
- MGNX N/A
- P/E Ratio
- ALTG N/A
- MGNX N/A
- Revenue Growth
- ALTG 6.51
- MGNX 16.68
- 52 Week Low
- ALTG $5.40
- MGNX $2.34
- 52 Week High
- ALTG $13.67
- MGNX $21.88
- Technical
- Relative Strength Index (RSI)
- ALTG 34.97
- MGNX 45.32
- Support Level
- ALTG $7.21
- MGNX $2.34
- Resistance Level
- ALTG $7.70
- MGNX $2.95
- Average True Range (ATR)
- ALTG 0.34
- MGNX 0.17
- MACD
- ALTG -0.09
- MGNX 0.03
- Stochastic Oscillator
- ALTG 3.85
- MGNX 61.76
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About MGNX MacroGenics Inc.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 x CTLA-4), Tebotelimab (PD-1 x LAG-3), MGD024 (CD123 x CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV x CD3).